Summary
Date: July 29, 2022
FDA Publish Date: July 29, 2022
Company Name: Edgewell Personal Care Company
Brand Name: Banana Boat
Product Description: Hair & scalp sunscreen spray
Company Announcement
Edgewell Personal Care Company today issued a voluntary nationwide recall of three batches of Banana Boat Hair & Scalp Sunscreen Spray SPF 30 due to possible trace levels of benzene.
While benzene is not an ingredient in any Banana Boat products, the review showed that unexpected levels of benzene came from the propellant that sprays the product out of the can.
Importantly, no other batches of Hair & Scalp (either before or after these batch codes) and no other Banana Boat products are in the scope of this recall and may continue to be used by consumers safely and as intended.
Risk Statement: Benzene is classified as a human carcinogen. Exposure to benzene can occur by inhalation, orally, and through the skin and it potentially can result in cancers including leukemia and blood cancer of the bone marrow and blood disorders which can be life-threatening. To date, Edgewell has not received any adverse events related to this recall. Benzene is ubiquitous in the environment. Humans around the world have daily exposure to it indoors and outdoors from multiple sources. Daily exposure to benzene in the recalled products would not be expected to cause adverse health consequences according to an independent health assessment using established exposure modelling guidelines.
The affected Banana Boat Hair & Scalp Sunscreen Spray SPF 30 sold by Kirk Market are:
0-79656-04041-8
Lot code: 21139AF
Expiry: April 2024
All affected products have been removed from our shelves. In order to keep our customers as safe as possible, we are requesting that if you have purchased any of these products from Kirk Market, you are urged to cease use and dispose of them immediately or return the product with the receipt for a full refund. The management of Kirk Market will continue to monitor this situation as the health and well being of our customers is our priority.
For more information, please visit the FDA Website